BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 748764)

  • 1. Castration effects on tumor-specific immunity.
    Brannen GE
    Natl Cancer Inst Monogr; 1978 Dec; (49):101-4. PubMed ID: 748764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Castration effects on tumor specific immunity.
    Brannen GE; Gomolka DM; Wettlaufer JN; Modarelli RO
    Invest Urol; 1977 Jul; 15(1):28-38. PubMed ID: 873734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of cell membrane antigens in prostate cancer.
    Brannen GE; Coffey DS
    Natl Cancer Inst Monogr; 1978 Dec; (49):251-3. PubMed ID: 86164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of heightened tumor immunity induced by cryosurgery.
    Faraci RP; Bagley DH; Marrone JC; Ketcham AS; Beazley RM
    Am Surg; 1975 May; 41(5):309-11. PubMed ID: 1130764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
    Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant immunity and specific desensitization in murine tumor hosts.
    Vaage J
    Isr J Med Sci; 1973 Mar; 9(3):332-43. PubMed ID: 4710041
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
    Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.
    Gleave ME; Hsieh JT; Wu HC; von Eschenbach AC; Chung LW
    Cancer Res; 1992 Mar; 52(6):1598-605. PubMed ID: 1371718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity.
    Bonventre PF; Nickol AD; Ball EJ; Michael JG; Bubel HC
    J Reticuloendothel Soc; 1982 Jul; 32(1):25-35. PubMed ID: 6290658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity of cell membrane antigens in prostatic cancer.
    Brannen GE; Gomolka DM; Coffey DS
    Cancer Chemother Rep; 1975; 59(1):127-38. PubMed ID: 1131799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of neuraminidase in experimental immunotherapy of two murine pulmonary carcinomas.
    Alley CD; Snodgrass MJ
    Cancer Res; 1977 Jan; 37(1):95-101. PubMed ID: 830425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prostate cancer (PC-82) in nude mice: a model to study androgen regulated tumor growth.
    van Steenbrugge GJ; Groen M; Bolt-de Vries J; Romijn JC; Schroeder FH
    Prog Clin Biol Res; 1985; 185A():23-50. PubMed ID: 4034577
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration.
    Frost GI; Lustgarten J; Dudouet B; Nyberg L; Hartley-Asp B; Borgström P
    Microvasc Res; 2005 Jan; 69(1-2):1-9. PubMed ID: 15797254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemoid reaction in BALB/c mice bearing primary tumors induced by 3-methylcholanthrene.
    Kodama T; Kawamura T; Kobayashi H
    Cancer Res; 1978 Mar; 38(3):713-5. PubMed ID: 626975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonimmune and immune surveillance. II. Effect of recipient's age, tumor immunogenicity, and neonatal thymectomy on tumor growth inhibition.
    Zinzar SN; Svet-Moldavsky GJ; Karmanova NV
    J Natl Cancer Inst; 1978 Sep; 61(3):737-45. PubMed ID: 278851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis.
    Kodama Y; Seyama T; Kamiya K; Yokoro K
    J Natl Cancer Inst; 1982 Sep; 69(3):595-605. PubMed ID: 7050499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to soluble tumor antigens in various stages of tumor growth.
    Brannen GE; Santos GW
    Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of non-specific resistance and specific immune response against tumours in mice by synthetic muramyl dipeptide.
    Nĕmecková S; Bubeník J; Jezek J; Zaoral M
    Folia Biol (Praha); 1982; 28(5):327-33. PubMed ID: 7173449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.